In Germany, there is a shortage of corona medicine remdesivir. According to Health Minister Jens Spahn, the Federal Republic has only a few hundred doses left.
A week ago, the ministry said it still had enough stock of the first drug approved by the European Union for treatment of Covid-19.
Minster Spahn urges to make the virus inhibitor in Europe as well. He would also commit himself to this. Remdesivir, a multi-virus remedy, is made by the American pharmaceutical company Gilead.
Recently, the British newspaper The Guardian reported that the United States had bought up almost all of the stock for the next three months, which would prevent other countries from getting the drug for the time being.